194
Participants
Start Date
December 2, 2019
Primary Completion Date
January 10, 2022
Study Completion Date
January 10, 2022
PF-06650833
400 mg QD
PF-06700841
45 mg QD
PF-06826647
400 mg QD
Placebo
placebo
Holdsworth House Medical Practice, Sydney
Premier Specialists Pty Ltd, Kogarah
Woden Dermatology, Phillip
Sinclair Dermatology, East Melbourne
Skin Health Institute Inc., Carlton
Veracity Clinical Research, Woolloongabba
Icahn School of Medicine at Mount Sinai, New York
Penn State Health Milton S. Hershey Medical Center, Hershey
Penn State Health Radiology - University Physician Center, Hershey
Paddington Testing Company, Inc, Philadelphia
Thomas Jefferson University Hospital, Philadelphia
Thomas Jefferson University, Philadelphia
Virginia Commonwealth University Medical Center, Richmond
MedaPhase Inc., Newnan
Advanced Medical Research PC, Sandy Springs
Georgia Skin Cancer and Aesthetic Dermatology, Watkinsville
Park Avenue Dermatology, Orange Park
Leavitt Medical Associates of Florida d/b/a Ameriderm Research, Ormond Beach
Total Dermatology Care Center, Jacksonville
Jacksonville Center for Clinical Research, Jacksonville
Riverchase Dermatology and Cosmetic Surgery, Pembroke Pines
University of Miami Hospital, Miami
Tory Sullivan MD PA, North Miami Beach
ForCare Clinical Research, Tampa
Alliance Clinical Research of Tampa, Tampa
Olympian Clinical Research Largo Office, Largo
Renstar Medical Research, Ocala
MidState Skin Institute, Ocala
Renstar Medical Research, Ocala
The University Of Alabama At Birmingham, Birmingham
The University of Alabama at Birmingham Hospital Outreach Lab, Birmingham
The University of Alabama at Birmingham Investigation Drug Services Pharmacy, Birmingham
The University of Alabama at Birmingham, Birmingham
Clinical Research Solutions, Jackson
Dermatology and Skin Cancer Consultants, Jackson
Dermatology and Skin Cancer Consultants, Humboldt
DS Research, Louisville
Dawes Fretzin Clinical Research Group, LLC, Indianapolis
Ds Research, Clarksville
Revival Research Institute, LLC, Troy
Wayne State University / Integrative Biosciences Center, Detroit
Clinical Research Unit, Minneapolis
Lillihei Clinical Research Unit, Minneapolis
University of Minnesota Department of Dermatology, Minneapolis
NorthShore University HealthSystem Dermatology Clinic, Skokie
Saint Louis University - Department of Dermatology, St Louis
MediSearch Clinical Trials, Saint Joseph
Skin Specialists PC, Omaha
Vital Prospects Clinical Research Institute, Tulsa
Arlington Research Center, Arlington
Austin Institute for Clinical Research, Inc., Pflugerville
University of Utah MidValley Dermatology, Murray
Mayo Clinic, Scottsdale
J Woodson Clinical Studies Group, Henderson
Keck School of Medicine of University of Southern California, Los Angeles
Clinical Science Institute, Santa Monica
Pacific Clinical Trials, Long Beach
UCSF Dermatology Clinic, San Francisco
University of California San Francisco, San Francisco
UCSF Psoriasis and Skin Treatment Center, San Francisco
Center for Dermatology Clinical Research, Inc., Fremont
Bellevue Dermatology Clinical Research Center, Bellevue
Bellevue Dermatology Clinic, Bellevue
Dermatology Associates of Seattle, Seattle
New England Research Associates, LLC, Bridgeport
Dermatology Physicians of Connecticut, Shelton
Boston Medical Center, Boston
Boston University General Clinical Research Unit, Boston
Beth Israel Deaconess Medical Center, Boston
SimcoDerm Medical and Surgical Dermatology Center, Barrie
Manna Research (London), London
DermEffects, London
SKiN Centre for Dermatology, Peterborough
The Centre for Dermatology, Richmond Hill
Diex Recherche Sherbrooke Inc., Sherbrooke
Centre de Recherche Saint-Louis, Québec
Alpha Recherche Clinique, Québec
Lead Sponsor
Pfizer
INDUSTRY